Has the referral of older adults with dementia changed since the availability of acetylcholinesterase inhibitors and the NICE guidelines?

Psychiatric Bulletin

Volumn 30, Issue 4, 2006, Pages 131-134

  O'Loughlin, Christopher ^a   Darley, Jon ^b  

^a FULBOURN HOSPITAL   (United Kingdom)

^b WEST SUFFOLK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; ELDERLY CARE; FEMALE; FRONTOTEMPORAL DEMENTIA; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PATIENT REFERRAL; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33645652160     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.30.4.131     Document Type: Article

References (11)

1. AD2000 COLLABORATIVE GROUP (2004) Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet, 363, 2105-2115.
2. AUDIT COMMISSION (2000) Forget Me Not. Mental Health Services for Older People. London: Audit Commission.
3. AUDIT COMMISSION (2002) Forget Me Not, Developing Mental Health Services for Older People in England London: Audit Commission http://www.audit-commission.gov.uk/Products/NATIONAL-REPORT/3DFEF403- 038C-464f-8518-441477E92B15/forgetupdate.pdf
4. DEPARTMENT OF HEALTH (2001) National Service Framework for Older People. London: Department of Health.
5. FOLSTEIN, M. F., FOLSTEIN, S. E. & MCHUGH, P. R. (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
6. MALOUF, R. & BIRKS, J. (2004) Donepezil for vascular cognitive impairment. Cochrane Library, issue 4, Oxford: Update Software.
7. McKEITH, I., DEL SER, T., SPANO, P., et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 326, 2031-2036
8. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2001) Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease.Technology Appraisal Guidance, no. 19. London: NICE.
9. O'BRIEN, J. & BALLARD, C. (2001) Drugs for Alzheimer's disease. BMJ, 323, 123-24.
10. SHELDON, J., CULLUM, N., DAWSON, D., et al (2004) What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ, 329, 999-1004.
11. WHITE, C. (2004) NICE guidance has failed to end "postcode prescribing". BMJ, 328, 1277.